The trkC locus encodes several receptors for neurotrophin-3, including the well studied full-length tyrosine kinase isoform, in addition to receptor isoforms lacking the kinase active domain. TrkC receptors are widely expressed throughout mouse development in many different organs. To investigate the function of truncated receptors in vivo and to identify cell types that are biologically responsive to this gene product, we have overexpressed a physiological truncated trkC isoform in the mouse. Mice overexpressing this receptor develop to term but die in the first postnatal days. High levels of transgene expression result in severe developmental defects in the peripheral nervous system and in the heart. The severity of neuronal losses observed in these animals suggests that truncated receptors may act by sequestering neurotrophin, thus, closely relating this mouse model to the neurotrophin-3-deficient one. Lower levels of exogenous truncated receptor in transgenic mice result in a more modest phenotype and, in some neuronal populations, do not cause neural deficits. Taken together, these data suggest that truncated trkC receptor isoforms may have modulatory functions in development.
Neurotrophins and their receptors are highly expressed throughout mouse ontogenesis in both neuronal and non-neural cell types (for review, see Tessarollo, 1998) . These families of genes play crucial roles in the development and f unction of the nervous system (Korsching, 1993; Snider, 1994; Bothwell, 1995; Lewin and Barde, 1996) . Neurotrophin activation of trk tyrosine kinase receptors results in the initiation of signal transduction cascades, including the ras pathway, and the induction of proliferation, survival, and differentiation of peripheral nervous system (PNS) and C NS neurons. Many f unctions of these tyrosine kinase receptors and their signaling mechanisms have been described (Segal and Greenberg, 1996) . The trkB and trkC loci additionally encode, by alternative splicing, receptor isoforms that lack the catalytic kinase domain (K lein et al., 1990; Middlemas et al., 1991; Tsoulfas et al., 1993; Valenzuela et al., 1993; Garner and Large, 1994) . The unique intracellular domains of truncated forms of both trkB and trkC are highly conserved in human, mouse, rat, and chicken (Garner and Large, 1994; Baxter et al., 1997) . The high conservation of these intracellular domains has raised the notion that truncated isoforms may have signaling ability.
Indeed, recent data obtained in vitro have shown that truncated trkB receptors can induce a ligand-mediated increase in the release of cellular acidic metabolites (Baxter et al., 1997) , and that activated truncated trkC receptors can promote differentiation of chicken neural crest cells (Hapner et al., 1998) . Mice lacking all trkC isoforms, including the truncated ones, have a more severe phenotype, including reduced viability and a more pronounced neuronal deficit, compared with mice lacking only the full-length tyrosine kinase receptors, suggesting a positive role for truncated trkC receptors in vivo (Klein et al., 1994; Minichiello et al., 1995; Tessarollo et al., 1997) . However, no signaling molecules downstream of truncated receptors have been identified to date.
The presence of abnormalities in mice heterozygous for a specific neurotrophin null allele has demonstrated that precise levels of neurotrophins are critical for normal mouse development (Ernfors et al., 1994; Korte et al., 1995; Donovan et al., 1996; Erickson et al., 1996; Chen et al., 1997) . Expression analysis of truncated trkB receptors and results obtained from coexpressing full-length and truncated trkB receptors have suggested that truncated receptors could act by sequestering excessive neurotrophins or as naturally occurring dominant negative elements of the full length receptor (Biffo et al., 1995; Eide et al., 1996; Ninkina et al., 1996) . However, there are as yet no in vivo data available in support of such nonsignaling functions of truncated receptors.
To investigate functions of truncated trkC receptors in vivo and to identify cell types that respond to these receptors, we have overexpressed a truncated trkC isoform in mouse. Ectopic expression of this truncated receptor results in perinatal lethality. Severe deficiencies were observed in sites that normally express endogenous truncated trkC receptors, such as the heart and the PNS (Hiltunen et al., 1996; Menn et al., 1998) . The effects on PNS development vary with the amount of transgenic mRNA expressed, suggesting that truncated trkC receptors may have pleiotropic modulatory functions in vivo.
MATERIALS AND METHODS

Generation of transgenic mice.
A trkC truncated f usion gene containing the human B-actin promoter and the SV40 poly(A) signal was constructed by inserting a 2.2 kb rat trkC truncated cDNA into the pHB APr-1 vector (Gunning et al., 1987) . This gene was microinjected into fertilized (C57BL /6J ϫ C3H / HeJ) F2 mouse eggs as previously described (Osborn et al., 1987) .
R Nase protection anal ysis. RNA was extracted using RNAzol (C inna / Biotecx) following the manufacturer's recommendations. RNase protection experiments were performed as previously described (Tessarollo et al., 1992 ) using a ribonuclease protection assay kit (Ambion). A genomic TrkC -specific probe that spans nucleotides 1238 -1424 of the extracellular domain (trkC -all) of the rat sequence was used to generate an antisense RNA probe used in RNase protection analysis to detect all trkC isoforms. The trkC truncated (TKϪ)-specific probe was obtained by subcloning a region of the rat trkC truncated receptor (nucleotides 1732 -1909 Tsoulfas et al., 1993) . The glyceraldehyde-3-phosphate dehydrogenase (GAPDH)-specific probe (Ambion) was included in the same reaction as a mean of assessing relative levels of RNA present in each hybridization.
Histolog ical techniques and neuronal cell counts. After microinjection, transgenic mice were checked for the presence of the transgene. Mutant and wild-type littermates were killed by decapitation, and the bodies and heads were immediately fixed in Bouin's fixative overnight. The next day, after rinsing for a few hours in water, the heads and spinal cords were transferred to 70% ethanol and processed for paraffin embedding. For neuronal counts, the heads of one transgenic littermate and one-wild type littermate were embedded in the same block, sectioned sagitally at 5 m, and Nissl-stained with 0.1% cresyl violet. To assure unbiased analysis, neuronal counts were performed in a blinded manner.
Immunohistochemical neurofilament staining. For immunohistochemistry, embryos fixed in 4% paraformaldehyde were bleached for 1 hr on ice in 3:1 methanol / hydrogen peroxide (30% solution in water), rehydrated, washed in PBS containing 0.1% T ween 20 (PBT), treated with proteinase K (20 g /ml) for 5 min, and refixed. Embryos were then incubated overnight at 4°C in 1% serum and mouse monoclonal anti-neurofilament 160 antibody (1:1000; Sigma Chemical Co., St. L ouis, MO), washed for 1 d in PBT, and incubated overnight at 4°C in PBT containing 1% serum and peroxidase-conjugated rabbit anti-mouse Ig (1:1000; Sigma). The color reaction was developed by incubation in 0.3 mg /ml diaminobenzidine, 0.03% H 2 O 2 , and 0.05% NiC l 2 and stopped by washing in PBT.
RESULTS
Generation of truncated trkC transgenic mice
The trkC gene is expressed in many tissues and at almost all stages of development Tsoulfas et al., 1993; Lamballe et al., 1994) . The specific pattern of expression of the different isoforms encoded by this locus is not known. However, truncated trkC receptors are expressed in both the PNS and CNS and, although at lower levels, in non-neural tissues, including the cardiovascular system Hiltunen et al., 1996; Menn et al., 1998) (Figure 1 A) . Thus, we have used the human ␤-actin promoter (Gunning et al., 1987) to drive the expression of a rat truncated trkC receptor that has a 36 amino acid domain that is 100% conserved between rat and chicken . Mouse and rat truncated trkC receptors Figure 1 . Expression of trkC receptors in truncated isoform transgenic animals. A, RNase protection analysis performed with a probe specific for the truncated trkC receptor (trkC TKϪ) reveals higher expression of endogenous trkC TKϪ in the brain compared with the leg in wild-type animals. Levels of expression of trkC TKϪ gene in transgenic animals are also shown. B, RNase protection analysis performed with an extracellular rat trkC antisense cDNA probe (all-trkC) that detects all isoforms of trkC RNA including the transgenic one (Tg). A polymorphism allows the distinction between the transgenic (bottom trkC band) from the wild-type mRNA (top band). C, High levels of expression of the transgene are associated with early postnatal lethality. RNA from legs of mice that were moribund at the indicated age (P0, P1, P3) was analyzed by RNase protection for the presence of the transgene (Tg TrkC TKϪ) by using the all-trkC probe. The endogenous trkC transcripts are also detected (Wt TrkC). Note that the time of death correlated with particular levels of expression of the transgene. In all experiments, a GAPDH antisense probe was included in the hybridization mixture to control for RNA loading.
are very conserved and are biologically indistinguishable; therefore, we used a rat truncated isoform to distinguish between the endogenous and the transgenic truncated receptor (P. Tsoulfas, personal communication) (Menn et al., 1998) . RNase protection experiments showed that indeed transgenic truncated trkC (Tg trkC TKϪ) RNA could be detected at high levels in both neural and non-neural tissues ( Fig. 1 A,B) .
Expression analysis of transgenic animals indicated that overexpression of this gene, even at high levels, did not impair embryo viability, because embryos could develop to term. However, transgenic mice fail to thrive when compared with their wild-type littermates, and several newborn pups died immediately after birth (Fig. 2) . Tissue analysis from mice that died immediately after birth revealed that they had the highest copy number of transgenic DNA (data not shown) and that they had the highest levels of the Tg trkC TKϪ transcript when compared with other transgenic animals that could live up to 9 d [postnatal day 9 (P9); Fig. 1C ]. Although we do not know the cause of death of these mice, their dusky appearance and immediate death suggested cardiac deficits as a potential cause. Histological evaluation of trkC TKϪ transgenic mouse hearts revealed abnormalities in the valvular architecture and cardiac septation. Some of the defects, including abnormally thickened aortic and semilunar valves and atrial septal defects, are shown in Figure 3 . These findings strongly suggest that cardiac dysf unction similar to that observed in the neurotrophin-3 (N T-3)-or trkC -deficient animals could play a role in the perinatal lethality associated with overexpression of the trkC truncated receptor (Donovan et al., 1996; Tessarollo et al., 1997) .
Peripheral nervous system deficiencies in mice expressing high levels of trkC truncated receptor
Newborn transgenic mice exhibited deficiencies in their movements and postures that resembled the proprioception defects observed in trkC and N T-3 mutant animals (Fig. 2) . To address whether these animals had PNS defects, we evaluated selected sensory and sympathetic neuronal populations of mice with the most severe phenotype (moribund at P0) compared with wildtype littermates. Severe reductions were observed in the trigeminal, geniculate, vestibular, and cochlear ganglia, whereas the petrosal-nodose ganglia displayed only a modest reduction. Also the superior cervical ganglion showed substantial neuronal losses when compared with controls. Thus, neuronal deficits in the transgenic animals are present in both sensory and sympathetic neuronal populations similar to the NT-3 mutant mouse (Table  1) . The development of an NT-3-like phenotype suggests that truncated receptors act by sequestering soluble neurotrophins. If truncated trkC receptor would act exclusively as dominant negative inhibitors of the full-length kinase active isoforms, the phenotype should be more similar to trkC-deficient mice. However, in contrast to mice lacking either the kinase active or all trkC receptors, the trkC TK-overexpressing mice develop severe sympathetic neuronal losses like the NT-3 knock-out mice (Table 1 ) (Tessarollo et al., 1997) .
PNS deficiencies arise before neuronal target innervation
We then asked at what stage of development the PNS of transgenic mice expressing high levels of the truncated trkC gene exhibited cell losses. Whole-mount analysis using an antibody that detects neurofilament 160 protein suggested normal development of the PNS in embryonic day 11 (E11) transgenic embryos when compared with wild-type littermates (Fig. 4 A,B) . However, by E13, reductions in the size of dorsal root ganglia (DRG) could be observed (Fig. 4C,D) . These results suggest that the deficits observed in newborn animals develop between E11 and E13 before neuronal target innervation occurs. Interestingly, NT-3 mutant mice also display reductions in trigeminal and DRG neurons at this time of development (Tessarollo et al., 1994; Fariñas et al., 1996; Wilkinson et al., 1996) . Therefore, the onset of neuronal deficits in the DRG of our transgenic mice is comparable with that observed in NT-3 null mutant mice.
PNS in mice expressing low levels of the trkC truncated receptor
Truncated trkC receptor expressed at high levels may act by neutralizing neurotrophins, as suggested by the fact that these transgenic mice develop a phenotype similar to that caused by NT-3 deficiency. As a result, this may mask the potential effects of a signaling function by the overexpressed truncated receptor in responsive cells. Thus, we analyzed mice with lower levels of the transgene. Such animals displayed a less-severe behavioral phenotype and prolonged viability (up to 9 d). Histopathological analysis of a variety of organs from mice that died at P9 showed no obvious abnormalities (data not shown). Neuronal counts of four sensory ganglia from this group of animals revealed reductions in the geniculate and the cochlear ganglia, although less severe than in mice expressing higher levels of the transgene. However, neuronal losses were higher in the petrosal-nodose ganglion. Surprisingly, we even observed a mild increase in the vestibular neuronal population (Table 2) . To investigate the specificity of this effect, we analyzed additional transgenic litters. Mice that died at P0 -P1 expressed high levels of the truncated trkC transgene as reported above. However, by P3 we were able to identify animals that displayed weight losses but only mild behavioral phenotypes. To avoid losing these mice, we killed them for analysis of their peripheral nervous system at P3 (Table 3) . We again observed neuronal losses in almost all investigated ganglia compared with controls. However, they were less severe than in the transgenic pups analyzed at P9. Most importantly, we observed again an increase in neuronal counts of the vestibular ganglia. This increase is not statistically significant; however, the reproducibility of this result suggests that this trkC truncated effect on the vestibular ganglia may be biologically significant.
DISCUSSION
Ectopic expression of truncated trkC receptors interferes with normal mouse development
The f unction of truncated trk neurotrophin receptor isoforms (lacking a f unctional cytoplasmic kinase domain) is still unknown. E xpression of truncated trkC receptors in cell lines, e.g., of the sympathoadrenal (PC12) and mesoderm (N IH3T3) lineages, failed to induce any apparent change in the cell cycle or cellular morphology (Tsoulfas, personal communication) . This result suggested that either these cells are lacking the signal transduction machinery downstream of this receptor, or the mechanism of action cannot be revealed because of the limitations of these in vitro systems. One goal of this study was to identify cell types responsive to truncated receptor functions in vivo. The truncated trkC receptor isoform that we used to generate transgenic mice is widely expressed in normal mouse development Valenzuela et al., 1993; Hiltunen et al., 1996; Menn et al., 1998) . In particular, it has been found throughout the CNS and PNS, including the DRGs and cranial ganglia (Menn et al., 1998) . Furthermore, its expression has also been detected in several organs outside the nervous system, including the cardiovascular system and mesodermal derivatives such as muscles Hiltunen et al., 1996; Menn et al., 1998) (Fig. 1 A) . Here we have shown that mice overexpressing this truncated trkC receptor at high levels die perinatally because of severe cardiac defects and PNS abnormalities. All the tissues for which we report defects normally do express endogenous truncated trkC receptors, suggesting specific functions for these receptors in the development of those organs (Hiltunen et al., 1996; Menn et al., 1998) . Despite the ubiquitous expression of trkC TKϪ in the transgenic animals, histological analysis to date Figure 3 . Cardiac defects in truncated trkC transgenic animals. A, Section of a newborn trkC TKϪ transgenic heart demonstrating an atrial septal defect (asd), markedly dilated atria with decreased trabeculations, and large septum primum. Magnification, 50ϫ. B, Higher magnification of A with asd, septum primum (sp), and septum secundum (ss) indicated by arrows. Magnification, 100ϫ. C-F, Sections through the pulmonic (C, D) and aortic (E, F ) valves of a normal (C, E) and a transgenic (D, F ) mouse heart. Magnification, 100ϫ. Note the thickening of the pulmonic ( pv) and aortic (av) valve leaflets (arrows) of the mutant animal compared with the control littermate. rv, Right ventricle; lv, left ventricle; ra, right atrium; la, left atrium; pa, pulmonic artery; ao, aorta; tv, tricuspid valve; mv, mitral valve. has failed to detect abnormalities in other organs (data not shown), suggesting that truncated receptors do not affect cell survival, proliferation, or differentiation per se.
NT-3-deficient mice and trkC TK؊ transgenic mice develop similar PNS and cardiac deficiencies
Expression analysis in rodents and chicken during development has shown the presence of truncated trkB and trkC receptors in non-neuronal tissues, and it has been suggested that these receptors act by limiting neurotrophic factors available to bind kinase active receptors (K lein et al., 1990; Tsoulfas et al., 1993; Valenzuela et al., 1993; Garner and Large, 1994; Biffo et al., 1995) . In fact, truncated trkB receptors in the ventricular zone of the spinal cord and the ependimal layer of ventricles in the brain provide a barrier to the diff usion of intraventricular injections of brainderived neurotrophic factor, consistent with the idea that this type of receptor could remove neurotrophins (Yan et al., 1994; Armanini et al., 1995; Biffo et al., 1995) . However, no data are available supporting such f unction during development. Here, we show that ubiquitous high-level expression of a truncated trkC isoform in mouse causes cardiac defects that resemble those of mice lacking the N T-3 or trkC gene (Donovan et al., 1996; Tessarollo et al., 1997) . However, N T-3-deficient mice develop more severe neuronal losses than trkC -deficient mice (Tessarollo et al., 1997;  Table 1 ). Overexpression of the trkC TKϪ transgene in the mouse results in PNS neuronal losses that most resemble the N T-3 null phenotype (Table 1) . Furthermore, the establishment of neuronal deficits occurs between E11.5 and E13.5, as reported for the N T-3 mutant mice Wilkinson et al., 1996) . These results support the hypothesis that truncated receptors f unction in neutralizing N T-3. However, we cannot rule out that the truncated receptor also inhibits the fulllength tyrosine kinase receptor directly by acting as a dominant negative receptor (Eide et al., 1996; Ninkina et al., 1996) . In fact, the observed co-expression of truncated and f ull-length trkC receptors in developing peripheral sensory neurons suggests such a role (Menn et al., 1998) . However, if this putative dominant negative f unction was the only mechanism of action by truncated isoforms, the phenotype of the transgenic mice would never be more severe than the one seen in trkC-deficient mice, which is not the case. Additionally, truncated trkC receptors could function as dominant negative inhibitors of trkA or trkB receptors. However, heterodimerization of different trk receptors has not been demonstrated in vivo, and none of the defects observed in the trkC TKϪ transgenic animal is characteristic of trkA or trkB null mutants (Klein et al., 1993; Smeyne et al., 1994) . For example, the proprioception deficits observed in the transgenic mice (Fig. 2) suggest that NT-3-trkC is the main ligand-receptor system affected in the trkC TKϪ overexpressing mice (Tessarollo, 1998) . Furthermore, trkA and trkB full-length receptors are not expressed in the heart during development (Hiltunen et al., 1996) . Thus, only inhibition of the full-length trkC receptors by truncated isoforms could account for the defects observed in the transgenic animals.
Modulatory effects of trkC TK؊ isoforms on PNS development
A noncatalytic receptor that controls NT-3 access to specific neuronal targets and that regulates the level of neurotrophins interacting with kinase active trk receptors can provide the organism with additional ways to increase functional diversity. Such a mechanism is even more relevant for a neurotrophin such as NT-3, which may have the ability to activate all trk family members and which is widely distributed during development (Bothwell, 1995; Lewin and Barde, 1996; Tessarollo, 1998) . However, it seems unlikely that an organism would need different types of truncated receptors just to regulate neurotrophin levels during ontogenesis. The high degree of conservation of intracellular domains of truncated receptors among species suggests other functions, such as signaling, for these receptors (Klein et al., 1990; Middlemas et al., 1991; Valenzuela et al., 1993; Garner and Large, 1994) .
Indeed recently, Hapner et al. (1998) have shown that ectopic overexpression of truncated trkC receptors in neural crest cells in vitro, although lacking any mitogenic effect, induces neural differentiation with participation of p75 LANR. This differentiation response is elicited only by a small subset of cells and is induced exclusively by truncated trkC receptors, which contain the evolutionarily conserved 39 amino acid intracellular domain, suggest- Reduction in neuronal cell counts of transgenic mice relative to wild-type mice were compared with those of trkCϪ/Ϫ and NT-3Ϫ/Ϫ mutant mice (Tessarollo et al., 1997) .
Tissue sections of newborn (P0) wild-type and mutant littermates were prepared as described in Materials and Methods. Neurons identified by a clear nucleus and nucleolus were counted in every sixth section, and the sum of counts was multiplied by 6. Values are not corrected and are expressed as mean number of neurons Ϯ SEM. Differences were evaluated using a one-tailed Student's test. In parenthesis, the numbers of animals analyzed are indicated. a From Tessarollo et al. (1997) .
*p Ͻ 0.005. **p Ͻ 0.02.
ing that specific intracellular domains of truncated receptors are required for activation of the differentiation pathway (Hapner et al., 1998) . Furthermore, it has been reported that truncated trkB receptors can induce a ligand-mediated increase in the rate of acidic metabolites released from the cells, a common physiological consequence of many signaling pathways. Again, a conserved, truncated, isoform-specific domain is required to induce this response (Baxter et al., 1997) . These data, although not providing information on the type of pathway activated by truncated receptors, do represent very intriguing results and suggest that both trkB and trkC truncated receptors activate intracellular signaling pathways. The variations observed in the PNS neuronal populations of trkC TKϪ transgenic mice, including a tendency to an increase in the number of neurons in the vestibular ganglia, are reciprocally related to the level of expression of the transgene, suggesting a modulatory role of truncated trkC on ganglia of the PNS (Tables  2, 3 ). The data are also consistent with the finding that mice lacking the truncated trkC isoforms, in addition to the full-length receptors, are missing 15% more DRG and 20% more cochlear ganglia neurons compared with mice lacking only the tyrosine kinase isoforms (Minichiello et al., 1995; Tessarollo et al., 1997) . The observation that changes in neuron numbers are limited in both transgenic (only a 10% increase in neurons in the vestibular ganglia) and knock-out animal models [20% fewer cochlear and DRG neurons in mice lacking both kinase and truncated trkC receptors compared with the ones lacking only the kinase iso- Figure 4 . Neuronal losses in mice overexpressing a truncated trkC receptor occur between embryonic days 11 and 13. The PNS of control ( A) and transgenic ( B) mice at day E11 of embryonic development was visualized by immunohistochemistry using an anti-neurofilament 160 antibody. No significant differences were detected between the PNS of the two embryos at this developmental stage. By E13, transgenic ( D) dorsal root ganglia (drg, arrow) are reduced in size when compared with wild-type drg (C, arrow) in sections at the same thoracic level. Cranial ganglia are indicated: TG, trigeminus with ophtalmic (op), maxillary (mx), and mandibular (md) branches; g, geniculate; V, vestibulocochlear; p, petrosal; n, nodose; O, optic nerve; SC, spinal cord; lu, lung. forms (Minichiello et al., 1995; Tessarollo et al., 1997) ] indicates that only a subset of neurons is responsive to the presence of truncated receptors. Indeed, the expression of endogenous truncated trkC receptors is restricted to a subset of DRG neurons at some stages of embryonic development. The identity and functional role of these neurons remain to be determined (Menn et al., 1998) . Different mechanisms, such as the ability of truncated receptors to remove ligand, inhibit the kinase active isoforms, or promote survival and /or differentiation, may not be mutually exclusive. The cellular environment may determine the mechanisms by which truncated receptors will exert their f unctions. Mice with conditional targeted alleles for truncated trkC receptor mutations may serve as tools to address specific signaling f unctions in vivo. Furthermore, such mouse strains would enable the investigation of a role of truncated receptors in the maturation process of the nervous system, an analysis that is now precluded by the limited life span of mice in which N T-3 and trkC receptor levels have been altered during development. 
